🇺🇸 FDA
Patent

US 8318467

Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

granted A61PA61P11/06A61P21/04

Quick answer

US patent 8318467 (Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P11/06, A61P21/04, A61P25/00, A61P25/16